The SIDER database of drugs and side effects
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Unwanted side effects of drugs are a burden on patients and a severe impediment in the development of new drugs. At the same time, adverse drug reactions (ADRs) recorded during clinical trials are an important source of human phenotypic data. It is therefore essential to combine data on drugs, targets and side effects into a more complete picture of the therapeutic mechanism of actions of drugs and the ways in which they cause adverse reactions. To this end, we have created the SIDER ('Side Effect Resource', http://sideeffects.embl.de) database of drugs and ADRs. The current release, SIDER 4, contains data on 1430 drugs, 5880 ADRs and 140 064 drug-ADR pairs, which is an increase of 40% compared to the previous version. For more fine-grained analyses, we extracted the frequency with which side effects occur from the package inserts. This information is available for 39% of drug-ADR pairs, 19% of which can be compared to the frequency under placebo treatment. SIDER furthermore contains a data set of drug indications, extracted from the package inserts using Natural Language Processing. These drug indications are used to reduce the rate of false positives by identifying medical terms that do not correspond to ADRs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, as SIDER was most recently updated in 2015, no currently up-to-date, computable databases exist for on-label ADEs.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, as SIDER was most recently updated in 2015, no currently up-to-date, computable databases exist for on-label ADEs.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“One of the most widely utilized ADE databases derived from drug label data is SIDER, constructed using a dictionary-based named entity recognition (NER) method to extract adverse event terms from FDA Structured Product Labeling (SPLs) drug labels13.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STRING v9.1: protein-protein interaction networks, with increased coverage and integration
Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M., Simonovic, M., Roth, A., Lin, J., Minguez, P., Bork, P., von Mering, C., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1094 · Cited by 4,398
Self-citationDrug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248 · cited 1×
“For example, it was shown that ADRs can be used to predict drug targets (1) and that causal relations between targets and ADRs can be elucidated (2,3).”
BackgroundSelf-citationThe Stanford typed dependencies representation
de Marneffe, M.-C., & Manning, C. D. (2008) · Coling 2008: Proceedings of the workshop on Cross-Framework and Cross-Domain Parser Evaluation - CrossParser '08 · doi:10.3115/1608858.1608859 · Cited by 918
A side effect resource to capture phenotypic effects of drugs
Kuhn, M., Campillos, M., Letunic, I., Jensen, L. J., & Bork, P. (2010) · Molecular Systems Biology · doi:10.1038/msb.2009.98 · Cited by 899
Self-citationPREDICT: a method for inferring novel drug indications with application to personalized medicine
Gottlieb, A., Stein, G. Y., Ruppin, E., & Sharan, R. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.26 · Cited by 881
STITCH 4: integration of protein–chemical interactions with user data
Kuhn, M., Szklarczyk, D., Pletscher-Frankild, S., Blicher, T. H., von Mering, C., Jensen, L. J., & Bork, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1207 · Cited by 487
Self-citationExtraction of potential adverse drug events from medical case reports
Gurulingappa, H., Mateen‐Rajpu, A., & Toldo, L. (2012) · Journal of Biomedical Semantics · doi:10.1186/2041-1480-3-15 · Cited by 211
The SPECIES and ORGANISMS Resources for Fast and Accurate Identification of Taxonomic Names in Text
Pafilis, E., Frankild, S. P., Fanini, L., Faulwetter, S., Pavloudi, C., Vasileiadou, A., Arvanitidis, C., & Jensen, L. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065390 · Cited by 206
Self-citationCai, M., Xu, Q., Pan, Y.-J., Pan, W., Ji, N., Li, Y.-B., Jin, H.-J., Liu, K., & Ji, Z. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1066 · Cited by 131
Systematic identification of proteins that elicit drug side effects
Kuhn, M., Al Banchaabouchi, M., Campillos, M., Jensen, L. J., Gross, C., Gavin, A., & Bork, P. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.10 · Cited by 120
Self-citation
Cited by
Items 401–500 of 1,001
Torres, L. H. M., Ribeiro, B., & Arrais, J. P. (2024) · Applied Soft Computing · doi:10.1016/j.asoc.2024.111268 · Cited by 30
Molecular pretraining models towards molecular property prediction
Qiao, J., Gao, W., Jin, J., Wang, D., Xu, G., Manavalan, B., & Wei, L. (2025) · Science China Information Sciences · doi:10.1007/s11432-024-4457-2 · Cited by 30
Identification of drug-side effect association via restricted Boltzmann machines with penalized term
Qian, Y., Ding, Y., Zou, Q., & Guo, F. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac458 · Cited by 30
Predicting anatomic therapeutic chemical classification codes using tiered learning
Olson, T., & Singh, R. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1660-6 · Cited by 30
Exact Pareto Optimal Search for Multi-Task Learning and Multi-Criteria Decision-MakingPreprint
Mahapatra, D., & Rajan, V. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2108.00597 · Cited by 30
Rationalizing Secondary Pharmacology Screening Using Human Genetic and Pharmacological Evidence
Deaton, A. M., Fan, F., Zhang, W., Nguyen, P. A., Ward, L. D., & Nioi, P. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy265 · Cited by 29
Salhi, A., Essack, M., Alam, T., Bajić, V., Ma, L., Radovanović, A., Marchand, B., Schmeier, S., Zhang, Z., & Bajić, V. B. (2017) · RNA Biology · doi:10.1080/15476286.2017.1312243 · Cited by 29
Kumar, D. M., & Talwar, P. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1616144 · Cited by 29
Shankar, S., Bhandari, I., Okou, D. T., Srinivasa, G., & Athri, P. (2020) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13802 · Cited by 29
DrugRepoBank: a comprehensive database and discovery platform for accelerating drug repositioning
Huang, Y., Dong, D., Zhang, W., Wang, R., Lin, Y.-C.-D., Zuo, H., Huang, H., & Huang, H. (2024) · Database · doi:10.1093/database/baae051 · Cited by 29
Wang, X., Yang, K., Jia, T., Gu, F., Wang, C., Xu, K., Shu, Z., Xia, J., Zhu, Q., & Zhou, X. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae161 · Cited by 29
Property-Aware Relation Networks for Few-Shot Molecular Property Prediction
Yao, Q., Shen, Z., Wang, Y., & Dou, D. (2024) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2024.3368090 · Cited by 29
Shi, Y., He, M., Chen, J., Han, F., & Cai, Y. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011989 · Cited by 29
The heterogeneous pharmacological medical biochemical network PharMeBINet
Königs, C., Friedrichs, M., & Dietrich, T. (2022) · Scientific Data · doi:10.1038/s41597-022-01510-3 · Cited by 29
Qiao, N., Wang, Y., Zhao, Y., Sun, J., Jiang, L., Wang, K., & Yin, M. (2024) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2024.103023 · Cited by 29
Repurposed Molecules: A New Hope in Tackling Neglected Infectious Diseases
Fernandez‐Prada, C., Douanne, N., Minguez-Menendez, A., Pena, J., Tunes, L. G., Pires, D. E. V., & do Monte‐Neto, R. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00005-5 · Cited by 29
Zhang, P., Wu, H., Chiang, C., Wang, L., Binkheder, S., Wang, X., Zeng, D., Quinney, S. K., & Li, L. (2018) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12267 · Cited by 29
Drug repurposing: An emerging strategy in alleviating skin cancer
Kumbhar, P., Kole, K., Yadav, T., Bhavar, A., Waghmare, P., Bhokare, R., Manjappa, A., Jha, N. K., Chellappan, D. K., Shinde, S., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175031 · Cited by 28
Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety
Goldring, C. E., Russomanno, G., Pin, C., Trairatphisan, P., Beattie, K. A., Fisher, C., Piñero, J., Brennan, R., Clausznitzer, D., Copple, I. M., et al. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01308-z · Cited by 28
Directions for Explainable Knowledge-Enabled SystemsPreprint
Chari, S., Gruen, D. M., Seneviratne, O. W., & McGuinness, D. L. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2003.07523 · Cited by 28
Scientific Algorithm Discovery by Augmenting AlphaEvolve with Deep ResearchPreprint
Liu, G., Zhu, Y., Chen, J., & Jiang, M. (2025) · arXiv (Cornell University) · doi:10.48550/arxiv.2510.06056 · Cited by 28
Farnoush, A., Sedighi‐Maman, Z., Rasoolian, B., Heath, J. J., & Fallah, B. (2024) · Scientific Reports · doi:10.1038/s41598-024-74505-2 · Cited by 28
Quantifying the Severity of Adverse Drug Reactions Using Social Media: Network Analysis
Lavertu, A., Hamamsy, T., & Altman, R. B. (2021) · Journal of Medical Internet Research · doi:10.2196/27714 · Cited by 28
Lin, S., Zhang, G., Wei, D., & Xiong, Y. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105984 · Cited by 28
Knowledge Graph Completion to Predict Polypharmacy Side Effects
Malone, B., García-Durán, A., & Niepert, M. (2018) · Lecture notes in computer science · doi:10.1007/978-3-030-06016-9_14 · Cited by 28
Mining and visualizing high-order directional drug interaction effects using the FAERS database
Yao, X., Tsang, T., Sun, Q., Quinney, S. K., Zhang, P., Ning, X., Li, L., & Shen, L. (2020) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-020-1053-z · Cited by 28
Chemical-induced disease extraction via recurrent piecewise convolutional neural networks
Li, H., Yang, M. Y., Chen, Q., Tang, B., Wang, X., & Yan, J. (2018) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-018-0629-3 · Cited by 28
CPMCP: a database of Chinese patent medicine and compound prescription
Sun, C. Y., Huang, J., Tang, R., Li, M., Yuan, H., Wang, Y., Wei, J., & Liu, J. (2022) · Database · doi:10.1093/database/baac073 · Cited by 28
Soldatos, T. G., Kim, S., Schmidt, S., Lesko, L. J., & Jackson, D. (2022) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12765 · Cited by 27
Large-Scale Multi-Omics Studies Provide New Insights into Blood Pressure Regulation
Kamali, Z., Keaton, J. M., Javanmard, S. H., Program, M. V., Edwards, T. L., Snieder, H., & Vaez, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147557 · Cited by 27
Network‐Based Approaches for Drug Repositioning
Song, T., Wang, G., Ding, M., Rodríguez‐Patón, A., Wang, X., & Wang, S. (2021) · Molecular Informatics · doi:10.1002/minf.202100200 · Cited by 27
Li, N., Chen, Z., Zhang, W., Li, Y., Huang, X., & Li, X. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.137575 · Cited by 27
Prediction of adverse drug reactions using drug convolutional neural networks
Mantripragada, A. S., Teja, S. P., Katasani, R. R., Joshi, P., Masilamani, V., & Ramesh, R. (2021) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720020500468 · Cited by 27
Hinnerichs, T., & Hoehndorf, R. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab548 · Cited by 26
Applications of Machine Learning in Drug Target Discovery
Gao, D., Chen, Q., Zeng, Y., Jiang, M., & Zhang, Y. (2020) · Current Drug Metabolism · doi:10.2174/1567201817999200728142023 · Cited by 26
Predicting combinative drug pairs towards realistic screening via integrating heterogeneous features
Shi, J., Li, J., Gao, K., Lei, P., & Yiu, S. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1818-2 · Cited by 26
Khan, J. Y., Khondaker, M. T. I., Hoque, I. T., Al-Absi, H. R. H., Rahman, M. S., Guler, R., Alam, T., & Rahman, M. S. (2020) · JMIR Medical Informatics · doi:10.2196/21648 · Cited by 26
do Nascimento, A. C. A., Prudêncio, R. B. C., & Costa, I. G. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8955-3_17 · Cited by 26
MGATRx: Discovering Drug Repositioning Candidates Using Multi-View Graph Attention
Yella, J., & Jegga, A. G. (2021) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3082466 · Cited by 26
Predicting Drug Interaction With Adenosine Receptors Using Machine Learning and SMOTE Techniques
Saad, A. I., Omar, Y. M. K., & Maghraby, F. A. (2019) · IEEE Access · doi:10.1109/access.2019.2946314 · Cited by 26
A Data-Driven Approach for Identifying Medicinal Combinations of Natural Products
Yoo, S., Ha, S., Shin, M., Noh, K., Nam, H., & Lee, D. (2018) · IEEE Access · doi:10.1109/access.2018.2874089 · Cited by 26
A survey on computational methods in discovering protein inhibitors of SARS-CoV-2
Liu, Q., Wan, J., & Wang, G. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab416 · Cited by 26
Zheng, Z., Tan, Y., Wang, H., Yu, S., Liu, T., & Liang, C. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbac566 · Cited by 26
Chong, L. C., Gandhi, G., Lee, J. M., Yeo, W. W. Y., & Choi, S. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168962 · Cited by 26
DrugRep-KG: Toward Learning a Unified Latent Space for Drug Repurposing Using Knowledge Graphs
Ghorbanali, Z., Zare‐Mirakabad, F., Akbari, M., Salehi, N., & Masoudi‐Nejad, A. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01291 · Cited by 26
Drug-induced QT Prolongation Atlas (DIQTA) for enhancing cardiotoxicity management
Li, S., Xu, Z., Guo, M., Li, M., & Wen, Z. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.10.009 · Cited by 26
Bromocriptine as a Novel Pharmacological Chaperone for Mucopolysaccharidosis IV A
Olarte-Avellaneda, S., Castillo, J. C. D., Rojas-Rodriguez, A. F., Sánchez, O. F., Rodríguez‐López, A., Súarez, D. A., Salazar, L. M., & Alméciga-Díaz, C. J. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00042 · Cited by 26
Névéol, A., & Zweigenbaum, P. (2017) · Yearbook of Medical Informatics · doi:10.15265/iy-2017-027 · Cited by 26
Lee, S., Kim, J., Oh, M.-S., Ryu, B., Kang, K.-R., Baek, J., Lee, J., Choi, S.-O., Kim, C., & Chung, H. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.03.039 · Cited by 26
ChemBioSim: Enhancing Conformal Prediction of In Vivo Toxicity by Use of Predicted Bioactivities
de Lomana, M. G., Morger, A., Norinder, U., Buesen, R., Landsiedel, R., Volkamer, A., Kirchmair, J., & Mathea, M. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00451 · Cited by 25
Henry, S., Wang, Y., Shen, F., & Uzuner, Ö. (2021) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocab153 · Cited by 25
Smit, I. A., Afzal, A. M., Allen, C. H. G., Svensson, F., Hanser, T., & Bender, A. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00294 · Cited by 25
Rausch, M., Weiss, A., Zoetemelk, M., Piersma, S. R., Jiménez, C. R., van Beijnum, J. R., & Nowak-Sliwinska, P. M. (2020) · Cancers · doi:10.3390/cancers12113172 · Cited by 25
Review of Natural Language Processing in Pharmacology
Trajanov, D., Trajkovski, V., Dimitrieva, M., Dobreva, J., Jovanovik, M., Klemen, M., Žagar, A., & Robnik‐Šikonja, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000715 · Cited by 25
CovidPubGraph: A FAIR Knowledge Graph of COVID-19 Publications
Pestryakova, S., Vollmers, D., Sherif, M. A., Heindorf, S., Saleem, M., Moussallem, D., & Ngomo, A.-C. N. (2022) · Scientific Data · doi:10.1038/s41597-022-01298-2 · Cited by 25
Pang, X., He, X., Yang, Y., Wang, L., Sun, Y., Cao, H., & Liang, Y. (2024) · Environment International · doi:10.1016/j.envint.2024.109244 · Cited by 25
Verstockt, B., Verstockt, S., Cremer, J., Sabino, J., Ferrante, M., Vermeire, S., & Sudhakar, P. (2023) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2022-001003 · Cited by 25
Shen, Y., Yuan, K., Yang, M., Tang, B., Li, Y., Du, N., & Lei, K. (2019) · Journal of Cheminformatics · doi:10.1186/s13321-019-0342-y · Cited by 25
Drug side effects prediction via cross attention learning and feature aggregation
Jin, Z., Wang, M., Zheng, X., Chen, J., & Tang, C. (2024) · Expert Systems with Applications · doi:10.1016/j.eswa.2024.123346 · Cited by 25
Das, P., Yogita, Y., & Pal, V. (2022) · Berichte aus der medizinischen Informatik und Bioinformatik/Journal of integrative bioinformatics · doi:10.1515/jib-2022-0007 · Cited by 25
Knowledge-augmented Graph Machine Learning for Drug Discovery: A Survey
Zhong, Z., Barkova, A., & Mottin, D. (2025) · ACM Computing Surveys · doi:10.1145/3744237 · Cited by 24
Zhu, J., Liu, Y., Wen, C., & Wu, X. (2020) · IEEE Transactions on Knowledge and Data Engineering · doi:10.1109/tkde.2020.2978055 · Cited by 24
Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder
Reay, W. R., Geaghan, M. P., Atkins, J., Carr, V. J., Green, M. J., & Cairns, M. J. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.07.011 · Cited by 24
Transform Drug Discovery and Development With Generative Artificial Intelligence
Lavecchia, A. (2025) · Wiley eBooks · doi:10.1002/9781394280735.ch25 · Cited by 24
Sboev, A. G., Sboeva, S., Александрович, М. И., Gryaznov, A. V., Борисович, Р. Р., Naumov, A., Selivanov, A., Rylkov, G., & Ilyin, V. (2022) · Applied Sciences · doi:10.3390/app12010491 · Cited by 24
AEGNN-M:A 3D Graph-Spatial Co-Representation Model for Molecular Property Prediction
Cai, L., He, Y., Fu, X., Zhuo, L., Zou, Q., & Yao, X. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3368608 · Cited by 24
DrugMAP 2.0: molecular atlas and pharma-information of all drugs
Li, F., Mou, M., Xiao-yi, L., Xu, W., Yin, J., Zhang, Y., & Zhu, F. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae791 · Cited by 24
Image-based molecular representation learning for drug development: a survey
Li, Y., Liu, B., Deng, J., Guo, Y., & Du, H. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae294 · Cited by 24
A pseudo-label supervised graph fusion attention network for drug–target interaction prediction
Xie, Y., Wang, X., Wang, P., & Bi, X. (2024) · Expert Systems with Applications · doi:10.1016/j.eswa.2024.125264 · Cited by 24
Cheng, X., Qu, J., Ni, T., Song, S., & Bian, Z. (2022) · PeerJ · doi:10.7717/peerj.13848 · Cited by 24
Wu, Y., Liu, Q., & Xie, L. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100452 · Cited by 24
A Trusted Healthcare Data Analytics Cloud Platform
Iyengar, A., Kundu, A., Sharma, U. K., & Zhang, P. (2018) · IEEE International Conference on Distributed Computing Systems (ICDCS) · doi:10.1109/icdcs.2018.00123 · Cited by 24
NDDSA: A network- and domain-based method for predicting drug-side effect associations
Shabani-Mashcool, S., Marashi, S., & Gharaghani, S. (2020) · Information Processing & Management · doi:10.1016/j.ipm.2020.102357 · Cited by 24
Mower, J., Subramanian, D., & Cohen, T. (2018) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocy077 · Cited by 24
Qi, H., Li, X., Zhang, C., & Zhao, T. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1589788 · Cited by 23
Skolnick, J., & Zhou, H. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c04525 · Cited by 23
Insights, opportunities, and challenges provided by large cell atlases
Hemberg, M., Marini, F., Ghazanfar, S., Al-Ajami, A., Abassi, N., Anchang, B., Benayoun, B. A., Cao, Y., Chen, K., Cuesta-Astroz, Y., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03771-8 · Cited by 23
Text summarization with ChatGPT for drug labeling documents
Ying, L., Liu, Z., Fang, H., Kusko, R. L., Wu, L., Harris, S., & Tong, W. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104018 · Cited by 23
COVID-19Base v3: Update of the knowledgebase for drugs and biomedical entities linked to COVID-19
Basit, S. A., Qureshi, R., Musleh, S., Guler, R., Rahman, M. S., Biswas, K. H., & Alam, T. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1125917 · Cited by 23
BatmanNet: bi-branch masked graph transformer autoencoder for molecular representation
Wang, Z., Feng, Z., Li, Y., Li, B., Wang, Y., Sha, C., He, M., & Li, X. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad400 · Cited by 23
Xuan, P., Wang, M., Liu, Y., Wang, D., Zhang, T., & Nakaguchi, T. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac126 · Cited by 23
ARCH: Large-scale knowledge graph via aggregated narrative codified health records analysis
Gan, Z., Zhou, D., Rush, E. N., Panickan, V. A., Ho, Y.-L. A., Ostrouchovm, G., Xu, Z., Shen, S., Xiong, X., Greco, K. F., et al. (2025) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2024.104761 · Cited by 23
Multiple similarity drug–target interaction prediction with random walks and matrix factorization
Liu, B., Papadopoulos, D., Malliaros, F. D., Tsoumakas, G., & Papadopoulos, A. N. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac353 · Cited by 23
RedMed: Extending drug lexicons for social media applications
Lavertu, A., & Altman, R. B. (2019) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2019.103307 · Cited by 23
Search to Fine-Tune Pre-Trained Graph Neural Networks for Graph-Level Tasks
Wang, Z., Di, S., Chen, L., & Zhou, X. (2024) · IEEE International Conference on Data Engineering (ICDE) · doi:10.1109/icde60146.2024.00219 · Cited by 23
Dasgupta, S., Jayagopal, A., Hong, A. L. J., Mariappan, R., & Rajan, V. (2021) · JMIR Medical Informatics · doi:10.2196/32730 · Cited by 23
Das, P., Sangma, J. W., Pal, V., & Yogita, Y. (2021) · Lecture notes in networks and systems · doi:10.1007/978-3-030-86258-9_17 · Cited by 23
Towards a more inductive world for drug repurposing approaches
de la Fuente, J., Serrano, G., Veleiro, U., Casals, M., Vera, L., Pizurica, M., Gómez-Cebrián, N., Puchades‐Carrasco, L., Pineda‐Lucena, A., Ochoa, I., et al. (2025) · Nature Machine Intelligence · doi:10.1038/s42256-025-00987-y · Cited by 22
Marzouk, N. H., Selim, S., Elattar, M., Mabrouk, M. S., & Mysara, M. (2025) · Journal of Cheminformatics · doi:10.1186/s13321-025-01093-2 · Cited by 22
Pandey, A., Kreimeyer, K., Foster, M. R., Dang, O., Ly, T., Wang, W., Forshee, R. A., & Botsis, T. (2018) · Health Informatics Journal · doi:10.1177/1460458217749883 · Cited by 22
Prediction of Side Effects Using Comprehensive Similarity Measures
Seo, S., Lee, T., Kim, M., & Yoon, Y. (2020) · BioMed Research International · doi:10.1155/2020/1357630 · Cited by 22
Jang, G., Lee, T., Hwang, S., Park, C., Ahn, J., Seo, S., Hwang, Y., & Yoon, Y. (2018) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2018.09.015 · Cited by 22
Pavel, A., Saarimäki, L. A., Möbus, L., Federico, A., Serra, A., & Greco, D. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.08.061 · Cited by 22
An Evaluation Benchmark for Adverse Drug Event Prediction from Clinical Trial Results
Yazdani, A., Bornet, A., Khlebnikov, P., Zhang, B., Rouhizadeh, H., Amini, P., & Teodoro, D. (2025) · Scientific Data · doi:10.1038/s41597-025-04718-1 · Cited by 22
Predicting gastrointestinal drug effects using contextualized metabolic models
Guebila, M. B., & Thiele, I. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007100 · Cited by 22
PathoPhenoDB, linking human pathogens to their phenotypes in support of infectious disease research
Kafkas, Ş., Abdelhakim, M., Hashish, Y., Kulmanov, M., Abdellatif, M., Schofield, P. N., & Hoehndorf, R. (2019) · Scientific Data · doi:10.1038/s41597-019-0090-x · Cited by 22
Kawazoe, Y., Imai, T., & Ohe, K. (2016) · JMIR Medical Informatics · doi:10.2196/medinform.5275 · Cited by 22
Drug repositioning based on tripartite cross-network embedding and graph convolutional network
Zeng, P., Zhang, B., Liu, A., Meng, Y., Tang, X., Yang, J., & Xu, J. (2024) · Expert Systems with Applications · doi:10.1016/j.eswa.2024.124152 · Cited by 22
MTMA: Multi-task multi-attribute learning for the prediction of adverse drug–drug interaction
Zhu, J., Liu, Y., & Wen, C. (2020) · Knowledge-Based Systems · doi:10.1016/j.knosys.2020.105978 · Cited by 22
Recent development of machine learning models for the prediction of drug-drug interactions
Hong, E., Jeon, J., & Kim, H. U. (2023) · Korean Journal of Chemical Engineering · doi:10.1007/s11814-023-1377-3 · Cited by 22
Metadata
- Authors
- Kuhn, M., Letunic, I., Jensen, L. J., & Bork, P.
- Affiliations
- Max Planck Institute of Molecular Cell Biology and Genetics (DE)
- University of Copenhagen (DK)
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-10-19
- Volume
- 44
- Issue
- D1
- Pages
- D1075-D1079
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC4702794
- OpenAlex
- W2145578524
- Cited by
- 1,451
- References
- 18
- Citations by year
- 2026: 123 · 2025: 199 · 2024: 194 · 2023: 160 · 2022: 156 · 2021: 183 · 2020: 131 · 2019: 111 · 2018: 82 · 2017: 74 · 2016: 37
- FWCI
- 51.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nucleic Acids Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- European Molecular Biology Laboratory
- Novo Nordisk (NNF14CC0001)
- Novo Nordisk Fonden (NNF 14CC0001)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- SIDER, adverse drug reactions, drug safety, drug indications, package inserts, natural language processing, therapeutic target
- MeSH terms
- Drug Labeling, Internet, Databases, Pharmaceutical, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.